Ham, Suji Kim, Tae Kyoo Sooyoung Chung Im, Heh-In 2024-01-20T02:30:23Z 2024-01-20T02:30:23Z 2021-09-01 2017-02 1226-2560 https://pubs.kist.re.kr/handle/201004/123139 Addictive drug use or prescribed medicine abuse can cause psychosis. Some representative symptoms frequently elicited by patients with psychosis are hallucination, anhedonia, and disrupted executive functions. These psychoses are categorized into three classifications of symptoms: positive, negative, and cognitive. The symptoms of DIP are not different from the symptoms of schizophrenia, and it is difficult to distinguish between them. Due to this ambiguity of distinction between the DIP and schizophrenia, the DIP animal model has been frequently used as the schizophrenia animal model. However, although the symptoms may be the same, its causes are clearly different in that DIP is acquired and schizophrenia is heritable. Therefore, in this review, we cover several DIP models such as of amphetamine, PCP/ketamine, scopolamine, and LSD, and then we also address three schizophrenia models through a genetic approach with a new perspective that distinguishes DIP from schizophrenia. English KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE ESCALATING DOSAGE SCHEDULE PREPULSE INHIBITION LATENT INHIBITION PREFRONTAL CORTEX GENE-EXPRESSION WORKING-MEMORY RECEPTOR HYPOFUNCTION PYRAMIDAL NEURONS INDUCED DEFICITS ANIMAL-MODEL Drug Abuse and Psychosis: New Insights into Drug- induced Psychosis Article 10.5607/en.2017.26.1.11 1 EXPERIMENTAL NEUROBIOLOGY, v.26, no.1, pp.11 - 24 EXPERIMENTAL NEUROBIOLOGY 26 1 11 24 scie scopus kci ART002202477 000406862000002 2-s2.0-85013853770 Medicine, Research & Experimental Neurosciences Research & Experimental Medicine Neurosciences & Neurology Review ESCALATING DOSAGE SCHEDULE PREPULSE INHIBITION LATENT INHIBITION PREFRONTAL CORTEX GENE-EXPRESSION WORKING-MEMORY RECEPTOR HYPOFUNCTION PYRAMIDAL NEURONS INDUCED DEFICITS ANIMAL-MODEL drug abuse psychosis drug induced psychosis schizophrenia animal model